Acadia Pharmaceuticals Inc (ACAD) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues | 11.15%342.29 | 307.96 | 268.06 | 283.99 | 278.63 |
| Cost Of Revenue | 23.92%35.09 | 28.32 | 24.79 | 26.23 | 21.65 |
0.66%159.20 | 160.25 | 171.02 | - | - | |
| Selling, General, and Administrative | 0.66%159.20 | 160.25 | 171.02 | - | - |
| Research and Development | 6.47%76.28 | 81.56 | 76.87 | - | - |
| Costs And Expenses | 0.17%270.57 | 270.12 | 272.68 | 266.60 | 242.88 |
| Operating Income/Loss | 89.55%71.72 | 37.84 | -4.62 | 17.39 | 35.76 |
| Income/Loss From Continuing Operations Before Tax | 73.09%80.44 | 46.47 | 3.98 | 26.32 | 44.60 |
| Income Tax Expense/Benefit | 79.76%26.92 | 14.97 | 0.34 | -247.25 | -27.18 |
69.92%53.52 | 31.50 | 3.64 | 273.57 | 71.78 | |
| Attributable To Parent | 69.92%53.52 | 31.50 | 3.64 | 273.57 | 71.78 |
| Available To Common Stockholders, Basic | 69.92%53.52 | 31.50 | 3.64 | 273.57 | 71.78 |
| Basic Average Shares | 0.55%172.55 | 171.60 | 170.52 | 0.52 | 168.84 |
| Diluted Average Shares | 1.51%175.47 | 172.85 | 172.71 | 0.76 | 170.65 |
| Basic Earnings Per Share | 72.22%0.31 | 0.18 | 0.02 | 1.62 | 0.43 |
| Diluted Earnings Per Share | 72.22%0.31 | 0.18 | 0.02 | 1.61 | 0.42 |